Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34132796.
- Also identified by DOI 10.1001/jamanetworkopen.2021.13739 and PMC identifier 8209575.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cross-sectional study evaluates the prevalence of proton pump inhibitor use among patients with cancer at 4 French comprehensive cancer centers.
Medical subject headings
- Drug Prescriptions
- Neoplasms
- Proton Pump Inhibitors